Talniflumate
탈니플루메이트
KDMF APIs중추신경계KDMF 등록
품목명 (영문)
Talniflumate
품목명 (한글)
탈니플루메이트
분류
중추신경계
CAS No.
66898-62-2
KDMF 등록번호
20100331-119-G-45-10(7)
제조원
Pen Tsao Chemical & Pharmaceutical Industry Co., Ltd.
규격
KP
IUPAC Name
3-oxo-1,3-dihydro-2-benzofuran-1-yl 2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylate
Description
Talniflumate, is an anti-inflammatory molecule studied and used as a mucin regulator in the treatment of cystic fibrosis, chronic obstructive pulmonary disease (COPD) and asthma. In addition, it is used in inflammatory conditions such as rheumatoid arthritis. Phase I trials with talniflumate for the treatment of cystic fibrosis and COPD were completed in August 2001, and phase II trials were performed in Ireland for the treatment of cystic fibrosis but this research has now been discontinued. Talniflumate has been approved for approximately 20 years in Argentina other countries (excluding the United States, Europe, and Japan).
Certificate of Analysis
If you need more information, please contact us.
규격서·시험성적서 등 추가 자료가 필요하시면 문의 시 함께 요청해 주세요. 담당자가 확인 후 회신합니다. (02-579-1056 · ace@acebiopharm.com)